ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Radici Pietro Industries & Brands SpA

Radici Pietro Industries & Brands SpA (RAD)

1.05
0.00
(0.00%)
Closed December 17 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.05
Bid
1.04
Ask
1.10
Volume
3,500
1.05 Day's Range 1.05
0.985 52 Week Range 1.35
Market Cap
Previous Close
1.05
Open
1.05
Last Trade
2500
@
1.05
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
5,256
Shares Outstanding
8,809,661
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
57.82M
Net Profit
463k

About Radici Pietro Industries & Brands SpA

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Website
Headquarters
Bergamo, Bergamo, Ita
Founded
-
Radici Pietro Industries & Brands SpA is listed in the Offices-holdng Companies sector of the Italian Stock Exchange with ticker RAD. The last closing price for Radici Pietro Industries... was 1.05 €. Over the last year, Radici Pietro Industries... shares have traded in a share price range of 0.985 € to 1.35 €.

Radici Pietro Industries... currently has 8,809,661 shares outstanding. The market capitalization of Radici Pietro Industries... is 9.25 € million.

RAD Latest News

Consolidated Summary Of September Retail Sales Results

The following companies are among those that have reported September retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (18.0%) (21.0%) Aeropostale ARO 19.0% 12.4...

Report: US Pharmacy Revenues To Surpass $350 Billion By 2015

By Dinah Wisenberg Brin Of DOW JONES NEWSWIRES U.S. pharmacies should generate more than $350 billion in prescription-drug revenue by 2015, an increase of some $100 billion from last year, with...

US EQUITIES WEEK AHEAD: Fed Meeting; World Leaders At UN, G20

The Federal Reserve could signal an exit strategy from the U.S. policy of monetary easing when it meets next week, according to analysts. Government reports are likely to show sales of new and...

Drug Stores Poised To Benefit From Potential H1N1 Resurgence

Drug stores are poised to benefit should a second wave of the H1N1 virus emerge in the U.S. How much the country's three largest drug chains, Walgreen Co. (WAG), Rite Aid Corp. (RAD) and CVS...

Consolidated Summary of August Retail Sales Results

The following companies are among those that have reported August retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (29.0%) (23.9%) Aeropostale ARO 9.0% 7.1...

Consolidated Summary of July Retail Sales Results

The following companies are among those that have reported July retail sales: Company SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (28.0%) (26.9%) Aeropostale ARO 6.0% 9.8...

Consolidated Summary Of June Retail Sales Results

The following companies are among those that have reported June retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (32.0%) (28.2%) Aeropostale ARO 12.0% 10.2...

Consolidated Summary Of June Retail Sales Results

The following companies are among those that have reported June retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Hot Topic HOTT (7.9%) (6.4%) Rite Aid RAD (0.6%) 1.4% Walgreen WAG 3.4% a...

UPDATE:DOJ Changes Policy On Pharma Pacts That Delay Generics

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs, the latest change in antitrust...

DOJ Changes Policy On Pharma Settlements That Delay Generics

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs, the latest change in antitrust...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-1.86915887851.071.091.0551671.07129032DE
40.021.941747572821.031.091.0132191.05058252DE
12001.051.221.0152561.10006961DE
260.010.9615384615381.041.241106481.11445037DE
52-0.08-7.07964601771.131.350.985134811.13399516DE
156-0.455-30.23255813951.5051.650.91296991.22746275DE
260-1.25-54.3478260872.32.430.912104781.48345675DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WERFOLaboratorio Farmaceutico Erfo SPA
0.0319 €
(29.67%)
3k
NVPNVP Spa
3.80 €
(25.83%)
42.5k
MNLMonnalisa SPA
0.97 €
(19.75%)
62.92k
1GMEGamestop Corporation
30.00 €
(13.98%)
9.07k
ATONAton Green Storage Spa
2.72 €
(13.33%)
229k
1VIVVivendi SE
2.562 €
(-69.13%)
1.31k
GSRAAG Rent AA
0.0005 €
(-66.67%)
606.1k
EVAAAAskoll Eva AA
0.0002 €
(-50.00%)
4.44M
1PANWPalo Alto Networks Inc
196.14 €
(-46.93%)
55
WFTC26Finanzatech Spa
0.0157 €
(-28.31%)
750
TITTelecom Italia SpA
0.2734 €
(-0.51%)
908.69M
TITRTelecom Italia
0.3102 €
(-0.03%)
116.47M
ISPIntesa Sanpaolo Spa
3.8715 €
(-1.83%)
36.69M
ENELEnel Spa
6.944 €
(-1.07%)
31.78M
BPEBper Banca SPA
6.136 €
(-2.57%)
14.72M

Discussion

View Full Feed
JMoneyHoops JMoneyHoops 46 seconds ago
Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ
EATR
dstock07734 dstock07734 50 seconds ago
Yes
NWBO
KILLAZILLA KILLAZILLA 2 minutes ago
DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......
TLRY
gitreal gitreal 2 minutes ago
...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i
NBRI
flipper44 flipper44 3 minutes ago
Those people know we can still see them, right?
NWBO
awesomed007 awesomed007 3 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
awesomed007 awesomed007 3 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
Eatatjoes Eatatjoes 3 minutes ago
Paul Malec of Deer Park, NY
QOIL
fuagf fuagf 3 minutes ago
Yeps, yeps and yeps. Good ones.
NoMoDo NoMoDo 3 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.
HMBL
manibiotech manibiotech 3 minutes ago
Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you 
NWBO
1vman 1vman 4 minutes ago
*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔
UBQU
janice shell janice shell 5 minutes ago
First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so
HappyAlways HappyAlways 5 minutes ago
I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t
FNMA
TheDane TheDane 6 minutes ago
Not only did it hold but it’s on the way back up.
SMCI
OnTrack444 OnTrack444 6 minutes ago
Might see a dime after the RS!  

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!!  Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!!  GLTY
HMBL
manibiotech manibiotech 7 minutes ago
Interesting for sure but not conclusive which he repeat every day 

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience 


NWBO
FACT-MASTER FACT-MASTER 8 minutes ago
Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i
CDMO
arizona1 arizona1 8 minutes ago
Never trumpers are hilarious and brilliant too.
jimr1717 jimr1717 10 minutes ago
“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is
SINT
NoMoDo NoMoDo 11 minutes ago
If we don't see a dime, I will be shocked.
HMBL
Slyhunter Slyhunter 11 minutes ago
I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is
TSLA
nfrequent nfrequent 11 minutes ago
Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/
RNVA
XMaster2023 XMaster2023 11 minutes ago
Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will
NWBO